Skip to main content
. Author manuscript; available in PMC: 2022 May 9.
Published in final edited form as: Eur Urol. 2020 Jul 2;78(5):661–669. doi: 10.1016/j.eururo.2020.06.043

Fig. 1 –

Fig. 1 –

Kaplan-Meier analysis depicting (A) overall survival, (B) clinical recurrence, (C) biochemical recurrence, and (D) ADT-free survival after salvage lymph node dissection. ADT = androgen deprivation therapy; BCR = biochemical recurrence; CR = clinical recurrence; SLND = salvage lymph node dissection.